Viewing nowRosuvastatin Calcium Tablets 20 mg
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201702135 · Approved 2017.04.26 · Insurance code 657307090
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medicine is used as an adjunctive therapy for patients with hypercholesterolemia and hyperlipidemia who cannot adequately control their condition through diet and exercise alone. It is particularly effective for patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and mixed hyperlipidemia, and it can be safely used in children who meet specific criteria. Moreover, it helps slow the progression of atherosclerosis by lowering total cholesterol and LDL cholesterol levels. It can also be used as an adjunct to diet in patients with primary dysbetalipoproteinemia. Furthermore, it contributes to the reduction of the risk of stroke, myocardial infarction, and revascularization procedures in high-risk adult populations with cardiovascular risk factors. Overall, this drug is used to control blood lipid levels and reduce the risk of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 mg daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Children under 10 years of age: Safety and efficacy have not been established.
This drug should not be used in certain patients. For example, patients who are allergic to any component of this medication, those with severely impaired liver function, patients with muscle disorders, those taking certain immunosuppressants, patients with severe kidney dysfunction, pregnant or breastfeeding women, and fertile women who are not using adequate contraception should not be administered this drug. Additionally, patients at high risk for muscle-related disorders or with specific genetic conditions, as well as those sensitive to lactose contained in this drug, should be cautious. This drug can affect liver function, so patients who consume alcohol heavily or have a history of liver disease should undergo regular liver function tests before and during treatment. If symptoms such as muscle pain or weakness occur, the doctor should be informed immediately, and if blood tests show elevated indicators of muscle injury along with these symptoms, discontinuation of the medication may be necessary. It is also advisable to discontinue this medication in cases of severe illness or acute conditions. Rarely, this drug may cause severe skin reactions or liver damage, so if symptoms like skin rash, jaundice, or severe fatigue appear, it is important to stop taking it immediately and consult healthcare personnel. This drug may interact with other medications, so it is essential to inform the doctor or pharmacist of any other medications being taken, particularly when using specific antiviral agents, immunosuppressants, antibiotics, or fibrate drugs. Pregnant or breastfeeding women should not use this medication, and women of childbearing age should employ proper contraceptive methods. There is no specific antidote for overdose, so treatment should be symptom-based, and liver function and muscle injury indicators should be tested. This drug may cause side effects such as dizziness, requiring caution when driving or operating machinery. Finally, Asian patients may demonstrate higher concentrations of this drug in the body, necessitating dose adjustments.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent exposure to air or moisture, and keep it at a safe temperature between 1°C and 30°C. This helps maintain the drug's effectiveness.
Pink round film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.